CarVin versus CarEto - A randomised phase II study of carboplatin and vinorelbine versus carboplatin and etoposide in good performance status small cell lung cancer patients presenting with adverse prognostic factors

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN44486227

Enrollment

Registered

2003-09-12

Start date

2002-04-08

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer: Small cell lung cancer Cancer Small cell lung cancer

Interventions

1. Chemotherapy with carboplatin and vinorelbine 2. Chemotherapy with carboplatin and etoposide Added July 2008: trial stopped because of poor recruitment

Eligibility

Inclusion criteria

Inclusion criteria: 1. Elderly patients >65 years with good prognosis and Eastern Cooperative Oncology Group (ECOG) p/s <2 2. Confirmed small cell lung cancer not considered eligible for aggressive multimodality therapy

Exclusion criteria

Exclusion criteria: Not provided at time of registration

Design outcomes

Primary

Measure	Time frame
1. Toxicity 2. Tumour response	—

Secondary

Measure	Time frame
Not provided at time of registration	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026